Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands

Microbial Drug Resistance

Volumn 16, Issue 1, 2010, Pages 55-60

  Sturm, Patrick D J ^a   Bochum, Els T M ^a   Van Mook Vermulst, Sacha V M ^a   Handgraaf, Cindy ^a   Klaassen, Twan ^a   Melchers, Willem J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; ENZYME ANALYSIS; EPSILOMETER TEST; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NETHERLANDS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACADEMIC MEDICAL CENTERS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; GENES, BACTERIAL; HUMANS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PREVALENCE; SEQUENCE ANALYSIS, DNA;

ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE;

EID: 77949588687     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0107     Document Type: Article

References (26)

1. Al Naiemi N., A. Bart, J. de, C.M. Vandenbroucke-Grauls, P.J. Rietra, Y.J. bets-Ossenkopp, P.C. Wever, L. Spanjaard, A.J. Bos, and B. Duim. 2006. Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands. J. Clin. Microbiol. 44:3012-3014.
2. Babini, G.S., and D.M. Livermore. 2000. Are SHV betalactamases universal in Klebsiella pneumoniae? Antimicrob. Agents Chemother. 44:2230.
3. Bonnet, R., C. Dutour, J.L. Sampaio, C. Chanal, D. Sirot, R. Labia, C.C. De, and J. Sirot. 2001. Novel cefotaximase (CTXM- 16) with increased catalytic efficiency due to substitution Asp-240?Gly. Antimicrob. Agents Chemother. 45:2269-2275.
4. Bush, K. 2008. Extended-spectrum beta-lactamases in North America, 1987-2006. Clin. Microbiol. Infect. 14 Suppl 1:134-143.
5. Carter, M.W., K.J. Oakton, M. Warner, and D.M. Livermore. 2000. Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method. J. Clin. Microbiol. 38:4228-4232.
6. [CLSI] Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing: Seventeenth Informational Supplement, M100-S17. Wayne, Pennsylvania.
7. Coque, T.M., F. Baquero, and R. Canton. 2008. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eur. Surveill. 13:1-11.
8. [EARSS] European Antimicrobial Resistance Surveillance System. 2008. EARSS annual report 2007. Available at www.rivm.nl=earss=. (Online, accessed 18 Nov. 2009.)
9. Fisher, M.A., P.D. Stamper, K.M. Hujer, Z. Love, A. Croft, S. Cohen, R.A. Bonomo, K.C. Carroll, and C.A. Petti. 2009. Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers. J. Med. Microbiol. 58:774-778.
10. Jacoby, G.A. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161-182, Table.
11. Jayaratne, A.H., D.L. Collins-Thompson, and J.T. Trevors. 1990. Influence of freezing-thawing and refrigeration on R-plasmid (pRPJ24) stability in Enterobacter cloacae 94R. Int. J. Food Microbiol. 11:143-150.
12. Koenig, G.L. 2003. Viability of and plasmid retention in frozen recombinant Escherichia coli over time: a ten-year prospective study. Appl. Environ. Microbiol. 69:6605-6609.
13. Mammeri, H., L. Poirel, and P. Nordmann. 2003. In vivo selection of a chromosomally encoded beta-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca. Antimicrob. Agents Chemother. 47:3739-3742.
14. Miro, E., C.M. del, F. Navarro, M. Sabate, B. Mirelis, and G. Prats. 1998. Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction. J. Antimicrob. Chemother. 42:535-538.
15. Monstein, H.J., A. Ostholm-Balkhed, M.V. Nilsson, M. Nilsson, K. Dornbusch, and L.E. Nilsson. 2007. Multiplex PCR amplification assay for the detection of blaSHV, bla- TEM and blaCTX-M genes in Enterobacteriaceae. APMIS 115:1400-1408.
16. Poirel, L., T. Le, I.T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.
17. Reinert, R.R., D.E. Low, F. Rossi, X. Zhang, C. Wattal, and M.J. Dowzicky. 2007. Antimicrobial susceptibility among organisms from the Asia=Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J. Antimicrob. Chemother. 60:1018-1029.
18. Rodriguez-Martinez, J.M., L. Poirel, P. Nordmann, C. Fankhauser, P. Francois, and J. Schrenzel. 2008. Ceftazidimeresistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland. Int. J. Antimicrob. Agents 32:278-279.
19. Sabate, M., E. Miro, F. Navarro, C. Verges, R. Aliaga, B. Mirelis, and G. Prats. 2002. Beta-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J. Antimicrob. Chemother. 49:989-997.
20. Sanguinetti, M., B. Posteraro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanetti, and G. Fadda. 2003. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method. J. Clin. Microbiol. 41:1463-1468.
21. Shannon, K., P. Stapleton, X. Xiang, A. Johnson, H. Beattie, B.F. El, B. Cookson, and G. French. 1998. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J. Clin. Microbiol. 36:3105-3110.
22. Steward, C.D., J.K. Rasheed, S.K. Hubert, J.W. Biddle, P.M. Raney, G.J. Anderson, P.P. Williams, K.L. Brittain, A. Oliver, J.E. McGowan, Jr., and F.C. Tenover. 2001. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J. Clin. Microbiol. 39:2864-2872.
23. Stobberingh, E.E., J. Arends, J.A. Hoogkamp-Korstanje, W.H. Goessens, M.R. Visser, A.G. Buiting, Y.J. bets- Ossenkopp, R.J. van Ketel,M.L. van Ogtrop, L.J. Sabbe,G.P. Voorn, H.L. Winter, and J.H. van Zeijl. 1999. Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals. Infection 27:348-354.
24. [SWAB] Stichting Werkgroep AntibioticaBeleid. 2009. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands. NethMap 2008. Available at www.swab.nl. (Online, accessed 18 Nov. 2009.)
25. Wiegand, I., H.K. Geiss, D. Mack, E. Sturenburg, and H. Seifert. 2007. Detection of extended-spectrum betalactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J. Clin. Microbiol. 45:1167-1174.
26. Wu, T.L., L.K. Siu, L.H. Su, T.L. Lauderdale, F.M. Lin, H.S. Leu, T.Y. Lin, and M. Ho. 2001. Outer membrane protein change combined with co-existing TEM-1 and SHV-1 betalactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:755-761.